These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 4701872)
41. [Renal tubular acidosis--clinical analysis of 46 cases]. Dong DC Zhonghua Nei Ke Za Zhi; 1983 Sep; 22(9):548-52. PubMed ID: 6653222 [No Abstract] [Full Text] [Related]
42. Metabolic acidosis with extreme elevation of anion gap: case report and literature review. Oster JR; Singer I; Contreras GN; Ahmad HI; Vieira CF Am J Med Sci; 1999 Jan; 317(1):38-49. PubMed ID: 9892270 [TBL] [Abstract][Full Text] [Related]
43. Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Muggia FM; Heinemann HO; Farhangi M; Osserman EF Am J Med; 1969 Sep; 47(3):351-66. PubMed ID: 5258033 [No Abstract] [Full Text] [Related]
45. [Metabolic acidosis]. Mattos LU Rev Enferm Nov Dimens; 1978; 4(2):73-6. PubMed ID: 24239 [No Abstract] [Full Text] [Related]
46. A case of osteomalacia and renal tubular acidosis associated with occult idiopathic steatorrhoea: the effect of vitamin D on renal tubular hydrion transport. Muldowney FP; Freaney R; Brennan P Ir J Med Sci; 1965 Dec; 6(480):435-48. PubMed ID: 5855113 [No Abstract] [Full Text] [Related]
47. Respiratory compensation to metabolic acid-base disturbances. Monti M; Rooth G Scand J Clin Lab Invest; 1970 Dec; 26(4):381-3. PubMed ID: 5486402 [No Abstract] [Full Text] [Related]
53. Copper deficiency associated with alkali therapy in a patient with renal tubular acidosis. Nishi Y; Kittaka E; Fukuda K; Hatano S; Usui T J Pediatr; 1981 Jan; 98(1):81-3. PubMed ID: 7452410 [No Abstract] [Full Text] [Related]
54. [Comparative evaluation of the alkalizing effect of absorbable and nonabsorbable antacids]. Dorofeev GI; Ivashkin VT Klin Med (Mosk); 1973 Feb; 51(2):97-100. PubMed ID: 4700840 [No Abstract] [Full Text] [Related]
55. Oral sorbents in uremia: charcoal-induced reduction in plasma lipids. Friedman EA Am J Med; 1977 Apr; 62(4):541-2. PubMed ID: 851128 [No Abstract] [Full Text] [Related]
56. Anion-exchange resins in treatment of uraemic acidosis and hyperphosphataemia. Wrong OM Lancet; 1973 Mar; 1(7801):493. PubMed ID: 4120414 [No Abstract] [Full Text] [Related]
57. [Hexacalcium-hexasodium-hepaticitrathydrate-complex (Acetolyt) in the treatment of nephrogenic metabolic acidosis]. Pogglitsch H; Schabasi H Med Klin; 1973 Feb; 68(7):206-11. PubMed ID: 4701872 [No Abstract] [Full Text] [Related]
58. [A hexacalcium-hexasodium-hepta-citrate-hydrate-complex in the treatment of kidney-dependent, metabolic acidosis]. Euchenhofer M; Würz H; Streicher E Med Welt; 1970 Oct; 42():1813-5. PubMed ID: 5471487 [No Abstract] [Full Text] [Related]
59. [Treatment of uremic acidoses. Clinical experiences with the drug acetolyt (U-124SV)]. Glet F Munch Med Wochenschr; 1971 May; 113(22):861-6. PubMed ID: 5108537 [No Abstract] [Full Text] [Related]
60. [Treatment of metabolic acidosis in patients with chronic renal insufficiency]. Oechslen D; Weingard D; Kluthe R Med Klin; 1971 Apr; 66(14):518-21. PubMed ID: 5552238 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]